Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes &ndash; a review

Código QR

Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes &ndash; a review

Katrine B Hansen1, Tina Vilsb&oslash;ll2, Filip K Knop21Department of Clinical Physiology, Glostrup Hospital, University of Copenhagen, Denmark; 2Diabetes Research Division, Department of Internal Medicine F, Gentofte Hospital, University of Copenhagen, DenmarkAbstract: Type 2 diabetes melli...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Katrine B Hansen, Tina Vilsb&oslash;ll, Filip K Knop
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/8c64de7374424824b9bf9975cd63ed86
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review
por: Knop FK, et al.
Publicado: (2010)

Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials
por: J&oslash;rn Ditzel, et al.
Publicado: (2009)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
por: Stanley Schwartz, et al.
Publicado: (2010)

Clinical utility of fixed combinations of sitagliptin&ndash;metformin in treatment of type 2 diabetes
por: Karen Barnard, et al.
Publicado: (2010)

Disturbance of inorganic phosphate metabolism in diabetes mellitus: clinical manifestations of phosphorus-depletion syndrome during recovery from diabetic ketoacidosis
por: J&oslash;rn Ditzel, et al.
Publicado: (2010)

SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin
por: Seufert J
Publicado: (2015)

Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase&ndash;lowering effects of garlic in patients with type 2 diabetes mellitus with obesity
por: Kumar R, et al.
Publicado: (2013)

Prevalence of overweight and obesity in adult Nigerians &ndash; a systematic review
por: Chukwuonye II, et al.
Publicado: (2013)

Long-term (52&ndash;78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients
por: Bays HE
Publicado: (2012)

Mechanisms of neuroprotective action of incretin mimetics
por: Timur Dmitrievich Vlasov, et al.
Publicado: (2016)

Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam &ndash; a clinical perspective
por: Ronald B Goldberg
Publicado: (2009)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
por: Schwartz S
Publicado: (2010)

AMPK activation: a therapeutic target for type 2 diabetes?
por: Coughlan KA, et al.
Publicado: (2014)

Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
por: Kedia N
Publicado: (2011)

Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination
por: Fleming JW, et al.
Publicado: (2015)

Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus
por: Whaley JM, et al.
Publicado: (2012)

Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-&kappa;B suppression
por: Sirada Rungseesantivanon, et al.
Publicado: (2010)

Management of gestational diabetes mellitus
por: Annunziata Lapolla, et al.
Publicado: (2009)

Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
por: Bo Ahr&eacute;n
Publicado: (2010)

Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions
por: Angel Rodr&iacute;guez, et al.
Publicado: (2010)

Role and development of GLP-1 receptor agonists in the management of diabetes
por: Chee&nbsp;W Chia, et al.
Publicado: (2009)

Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
por: Lindsay Zilliox, et al.
Publicado: (2010)

Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes
por: Cyrus&nbsp;V Desouza, et al.
Publicado: (2009)

Glycemic control and anti-osteopathic effect of propolis in diabetic rats
por: Al-Hariri M,&nbsp;Gamal Eldin T, et al.
Publicado: (2011)

Comorbidity and glycemia control among patients with type 2 diabetes in primary care
por: Catherine Hudon, et al.
Publicado: (2008)

Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD–scid IL-2rgnull RIP-DTR mice engrafted with human islets
por: Yang C, et al.
Publicado: (2015)

NDSP 09: Risk Assessment of Pakistani Individual for Diabetes (RAPID) – Findings from Second National Diabetes Survey of Pakistan (NDSP) 2016–2017
por: Abdul Basit K, et al.
Publicado: (2021)

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin
por: Schwartz SS, et al.
Publicado: (2016)

Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
por: Sweeting AN, et al.
Publicado: (2014)

Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico
por: Hirales-Tamez O, et al.
Publicado: (2012)

Metabolic syndrome in hemodialysis patients as a risk factor for new-onset diabetes mellitus after renal transplant: a prospective observational study
por: Bonet J, et al.
Publicado: (2013)

Tackling obesity: new therapeutic agents for assisted weight loss
por: JG Karam, et al.
Publicado: (2010)

Hearing thresholds in adult Nigerians with diabetes mellitus: a case–control study
por: Nwosu JN, et al.
Publicado: (2017)

Astragalus–Saffron–Rhubarb Mixture Delays the Progress of Diabetic Nephropathy in db/db Mice
por: Zhou XC, et al.
Publicado: (2021)

Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR&reg; TS
por: Przemyslaw Holko, et al.
Publicado: (2011)

Evaluation of single nucleotide polymorphisms of Pro12Ala in peroxisome proliferator-activated receptor-&gamma; and Gly308Ala in tumor necrosis factor-&alpha; genes in obese Asian Indians: a population-based study
por: Namita Bhagat, et al.
Publicado: (2010)

Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor
por: Zheng X, et al.
Publicado: (2015)

Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential
por: Bastin M, et al.
Publicado: (2019)

The Therapeutic Role of Carotenoids in Diabetic Retinopathy: A Systematic Review
por: Fathalipour M, et al.
Publicado: (2020)

Determinants of Diabetic Foot Ulcer Among Adult Patients with Diabetes Attending the Diabetic Clinic in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: Unmatched Case–Control Study
por: Woldemariam GT, et al.
Publicado: (2020)